ADC Therapeutics SA Files 2024 10-K
Ticker: ADCT · Form: 10-K · Filed: Mar 27, 2025 · CIK: 1771910
| Field | Detail |
|---|---|
| Company | Adc Therapeutics SA (ADCT) |
| Form Type | 10-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
ADC Therapeutics SA dropped its 2024 10-K. Check financials for Q4.
AI Summary
ADC Therapeutics SA filed its 2024 10-K on March 27, 2025, detailing its financial performance for the fiscal year ending December 31, 2024. The company, based in Epalinges, Switzerland, operates in the pharmaceutical preparations sector. The filing covers its business operations, financial statements, and risk factors, providing a comprehensive overview for investors.
Why It Matters
This 10-K filing provides crucial financial and operational details for ADC Therapeutics SA, allowing investors and analysts to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, ADC Therapeutics SA faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 2023 — Prior Fiscal Year (For comparative financial analysis)
Key Players & Entities
- ADC Therapeutics SA (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-27 (date) — Filing date
- Epalinges, Switzerland (location) — Company headquarters
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What were ADC Therapeutics SA's total revenues for the fiscal year ended December 31, 2024?
The filing indicates financial data for the fiscal year ended December 31, 2024, but specific revenue figures are not detailed in the provided header information.
When did ADC Therapeutics SA file its 10-K for the fiscal year 2024?
ADC Therapeutics SA filed its 10-K for the fiscal year 2024 on March 27, 2025.
What is the Standard Industrial Classification code for ADC Therapeutics SA?
The Standard Industrial Classification code for ADC Therapeutics SA is 2834, which corresponds to Pharmaceutical Preparations.
Where is ADC Therapeutics SA headquartered?
ADC Therapeutics SA is headquartered in Epalinges, Switzerland.
What period does the 'CONFORMED PERIOD OF REPORT' cover?
The 'CONFORMED PERIOD OF REPORT' covers the fiscal year ending December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 27, 2025 regarding ADC Therapeutics SA (ADCT).